BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6205174)

  • 1. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer].
    Hishnuma S
    Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1449-60. PubMed ID: 3785134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
    Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers of pancreatic cancer].
    Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic usefulness of serum levels of pancreatic oncofetal antigen (POA) and CA 19-9 in pancreatic cancers: monitoring of postoperative recurrences].
    Takami H; Hishinuma S; Shintoku J; Ogata Y; Abe O
    Gan No Rinsho; 1985 May; 31(6 Suppl):631-7. PubMed ID: 3861883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum levels of DUPAN2 antigen and CA19-9 in pancreatic cancer: correlation with immunocytochemical localization of antigens in cancer cells.
    Suzuki Y; Ichihara T; Nakao A; Sakamoto J; Takagi H; Nagura H
    Hepatogastroenterology; 1988 Jun; 35(3):128-35. PubMed ID: 3042577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoperoxidase detection of pancreatic oncofetal antigen in human tissues.
    Kawa S
    Gastroenterol Jpn; 1985 Aug; 20(4):361-7. PubMed ID: 3902552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification, partial characterization, and clinical evaluation of an adenocarcinoma-associated antigen.
    Pinto VB; Gelder FB; Morris DM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6520-4. PubMed ID: 3536083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentration and immunohistochemical localization of SPan-1 antigen in pancreatic cancer. A comparison with CA19-9 antigen.
    Takeda S; Nakao A; Ichihara T; Suzuki Y; Nonami T; Harada A; Koshikawa T; Takagi H
    Hepatogastroenterology; 1991 Apr; 38(2):143-8. PubMed ID: 1855772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic oncofetal antigen and carbohydrate antigen 19-9 in sera of patients with cancer of the pancreas.
    Shahangian S; Fritsche HA; Hughes JI; Gelder FB
    Clin Chem; 1989 Mar; 35(3):405-8. PubMed ID: 2537687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
    Harmenberg U; Wahren B; Wiechel KL
    Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated pancreatic oncofetal antigen levels measured by enzyme immunoassay in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Yoshikawa T; Fukumoto K; Kondo M
    Oncology; 1986; 43(5):311-5. PubMed ID: 3531954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigens associated with cancer of the pancreas].
    Burtin P
    Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on an oncofetal antigen, POA.
    Gelder F; Reese C; Moossa AR; Hunter R
    Cancer; 1978 Sep; 42(3 Suppl):1635-45. PubMed ID: 101295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen levels in pancreatic carcinoma.
    Paloyan D; Simonowitz D
    Am Surg; 1977 Jun; 43(6):410-2. PubMed ID: 869334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of tumor-associated antigen of the digestive tract by monoclonal antibody].
    Imai K; Hinoda Y; Yachi A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2185-90. PubMed ID: 3606145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of a serum pancreatic tumor marker: the carbohydrate antigen C.A. 19-9].
    Vincent D; Venot J; Catanzano G; Clément MN; Piquet MF; Veyriras E; Beck C
    Ann Med Interne (Paris); 1985; 136(2):142-4. PubMed ID: 3865571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of a pancreatic oncofetal antigen (POA) in carcinoma of the pancreas].
    Hishinuma S; Takami H; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Miyoshi K; Ishii T; Yamamori S
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1432-7. PubMed ID: 6097615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.